Skip to main content
Transgenic zebrafish to direct epicardial gene expression

Transgenic zebrafish to direct epicardial gene expression

Technology Duke inventors have generated a novel zebrafish model that allows researchers to study epicardial cells during embryonic heart development and myocardial regeneration. This zebrafish line is termed Tg(tcf21:CreER)pd42. Specifically, this transgenic model was created…

Read More

iPSC line to identify novel therapies for ARVC

iPSC line to identify novel therapies for ARVC

Technology Duke inventors have developed a novel induced pluripotent stem cell (iPSC) line that contains a mutation that impacts the TAX1BP3 gene, which causes arrhythmogenic right ventricular cardiomyopathy/dysplasia (ARVC). Specifically, the iPSCs were derived from…

Read More

Human B2-adrenergic receptor CHW cell line

Human B2-adrenergic receptor CHW cell line

Technology Duke inventors have generated a chinese hamster fibroblast cell line that expresses the human β2–adrenegic receptor.

Read More

A novel acoustic biomarker for quality of life in LVAD recipients

A novel acoustic biomarker for quality of life in LVAD recipients

Unmet Need Left ventricular devices (LVADs) are surgically implanted pumps that improve survival in patients with advanced heart failure. According to St. Judes, in the U.S. in 2016, over 7% of LVAD users reported poor…

Read More

Harvis: an interactive virtual reality tool for modification and simulation of blood flow

Harvis: an interactive virtual reality tool for modification and simulation of blood flow

Unmet Need Cardiovascular disease (CVD) is the largest underlying cause of mortality in the United States, causing one in every three deaths and costing an estimated $316 billion dollars a year. In recent years, computational…

Read More

Have Questions?

Please contact us or subscribe for more opportunities

Stay in Touch with Us